Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q09305

Entry ID Method Resolution Chain Position Source
AF-Q09305-F1 Predicted AlphaFoldDB

No variants for Q09305

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q09305

No associated diseases with Q09305

2 regional properties for Q09305

Type Name Position InterPro Accession
conserved_site Aminoacyl-tRNA synthetase, class I, conserved site 39 - 49 IPR001412
domain RNA-binding S4 domain 352 - 414 IPR002942

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

1 GO annotations of biological process

Name Definition
spliceosomal tri-snRNP complex assembly The formation of a tri-snRNP complex containing U4 and U6 (or U4atac and U6atac) snRNAs and U5 snRNAs and associated proteins. This includes reannealing of U4 and U6 (or U4atac and U6atac) snRNAs released from previous rounds of splicing to reform the U4/U6 snRNP (or U4atac/U6atac snRNP) as well as the subsequent association of the U5 snRNP with the U4/U6 snRNP (or U4atac/U6atac snRNP) to form a tri-snRNP that is ready to reassemble into another spliceosome complex.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q08DJ7 AAR2 Protein AAR2 homolog Bos taurus (Bovine) PR
Q9Y312 AAR2 Protein AAR2 homolog Homo sapiens (Human) PR
Q9D2V5 Aar2 Protein AAR2 homolog Mus musculus (Mouse) PR
10 20 30 40 50 60
MGGALPPEIV DYMYRNGAFL LFLGFPQASE FGIDYKSWKT GEKFMGLKMI PPGVHFVYCS
70 80 90 100 110 120
IKSAPRIGFF HNFKAGEILV KKWNTESETF EDEEVPTDQI SEKKRQLKNM DSSLAPYPYE
130 140 150 160 170 180
NYRSWYGLTD FITADTVERI HPILGRITSQ AELVSLETEF MENAEKEHKD SHFRNRVDRE
190 200 210 220 230 240
NPVRTRFTDQ HGLPIMKIRE GYEIRFQDIP PLTVSQNRVG IEYSDRLYRL LRALGGDWKQ
250 260 270 280 290 300
LLAEMQIAFV CFLQGQVFEG FEQWKRIIHL MSCCPNSLGS EKELFMSFIR VLFFQLKECP
310 320 330 340 350
TDFFVDIVSR DNFLTTTLSM LFANVRDSAH AGDDLKKKTA QFKQYLTNQF KWDFNCD